相关实验视频
Updated: Feb 12, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.4K
端粒缩短在拉米诺病扩张性心肌病症中
Alex C Y Chang1,2,3, Gaspard Pardon4,5, Andrew C H Chang4,5
1Department of Cardiology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. alexchang@shsmu.edu.cn.
NPJ Regenerative medicine
|February 10, 2026
概括
由LMNA基因突变引起的细膜病变会导致心脏问题和加快衰老. 这项研究表明,LMNA突变会导致心脏细胞的端粒缩短,将拉米诺病与衰老联系起来.
科学领域:
- 心血管生物学 心血管生物学
- 衰老的遗传学 衰老的遗传学
- 罕见疾病 罕见疾病
背景情况:
- 拉米诺病是一种罕见的遗传性疾病,源于LMNA基因的突变.
- LMNA对核结构和细胞稳定至关重要,影响肌肉,神经和心脏.
- 层状病变和加速衰老之间存在联系,但潜在的机制尚不清楚.
研究的目的:
- 研究将LMNA突变与心脏老龄化表型联系起来的细胞和分子机制.
- 探索端粒长度在拉米尼病相关心脏功能障碍中的作用.
主要方法:
- 从人体拉米诺发性心脏组织中分析心肌细胞.
- 使用患者衍生的诱导性多能干细胞衍生的心肌细胞 (hiPSC-CMs) 具有LMNA突变.
- 采用了拉米诺巴特性小鼠心肌细胞模型.
主要成果:
- 来自拉米诺心脏的心肌细胞表现出缩短的端粒.
- 在hiPSC-CMs中LMNA突变导致心肌扩大和收缩能力受损.
- 拉米诺病的小鼠心肌细胞表现出端粒磨损.
结论:
- 通过端粒缩短,LMNA突变有助于拉米诺病的心脏功能障碍.
- 这项研究提供了拉米诺病症和衰老过程之间的细胞联系.
- 端粒磨损是层状心肌病的关键表型.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
589
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Telomeres and Telomerase
27.4K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
27.4K
Telomeres and Telomerase
7.4K
7.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
526
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
Cardiomyopathy IV: Restrictive Cardiomyopathy
587
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
Cardiomyopathy V: Interprofessional Care
470
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470

